Victory Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Victory Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,055	Closed	-$252K	–	2611
2023 Q4	$252K	Buy	+4,055	New	+$101K	﹤0.01%	2175

Victory Capital Management's RYZB Position: Q1 2024 in Review

Victory Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 4,055 shares — an estimated $252K sold.

Victory Capital Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $252K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Victory Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Victory Capital Management sold 4,055 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $252K.
Victory Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Victory Capital Management's RayzeBio, Inc. Common Stock position peaked at $252K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Victory Capital Management's 13F filing for Q1 2024, filed 3 May 2024.